Pharmaceutical

Merck and ICR enter renewed cancer drug discovery partnership

Merck KGaA and the ICR have entered into a renewed strategic collaboration to discover and develop new therapeutics for treating cancer.

Sep 25, 2023 - 20:00
Merck and ICR enter renewed cancer drug discovery partnership
Merck KGaA and the ICR have entered into a renewed strategic collaboration to discover and develop new therapeutics for treating cancer.
Read the original article

Tags:

Previous Article

Valneva receives JE vaccine supply contract from US DoD

Next Article

Boehringer and Lilly gain FDA approval for kidney disease therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Gaza, Ukraine, and other conflicts could be accelerating antibiotic resistance

Opinion: Gaza, Ukraine, and other conflicts could be ac...

Dec 29, 2023

NICE expands access of Paxlovid to further 1.4 million Covid-19 patients

NICE expands access of Paxlovid to further 1.4 million ...

Jan 11, 2024

STAT+: Burning questions for the 2024 JPM Healthcare Conference

STAT+: Burning questions for the 2024 JPM Healthcare Co...

Jan 4, 2024